A working complaint handling system is a core part of any quality system. Every complaint about a product has to be evaluated and, where needed, investigated and analyzed, with corrective action taken. This 90-minute complaint handling and management webinar follows that process from receipt to trending.
You'll see how CAPA connects to complaint investigations, which tools teams use to investigate, how deep an investigation should go and why risk-based thinking matters for each decision. The session highlights regulatory expectations for both pharmaceuticals and medical devices, current FDA focus areas, and benchmarks for timely, closed-loop investigations.
WHY SHOULD YOU ATTEND?
Complaints are a strong signal of problems with how a product is used, designed or made, and they cannot be ignored. One well-investigated complaint can prompt corrective action, while trends across many complaints can drive changes to a product, its labeling, packaging or distribution.
This session helps QA, QC, compliance, regulatory, engineering, operations, sales, customer service staff, managers and consultants decide whether a complaint is valid, find the root cause and prevent repeats.
AREA COVERED
- How and why CAPA is tied to product complaint investigations
- Tools currently used to conduct investigations
- How far and how deep to take an investigation
- Current FDA hot buttons and trends
- Benchmarks and best practices for investigations
- Becoming a good investigator and the focus on closed-loop investigations
- Why risk-based approaches are vital to decision-making
- Strengthening your product complaint management system through investigations
LEARNING OBJECTIVES
- Explain how CAPA links to product complaint investigations
- Choose suitable tools for complaint investigations
- Decide how far and how deep an investigation needs to go
- Recognize current FDA hot buttons and trends
- Apply risk-based approaches to complaint decisions
- Run closed-loop investigations using benchmarks and best practices
- Strengthen your complaint management system
WHO WILL BENEFIT?
- All levels of Management for all departments and those who desire a better understanding
- QA/QC/Compliance/Regulatory Affairs
- Marketing & Sales & Customer Service
- Engineering/Technical Services
- Consultants
- Operations and Manufacturing
Complaints are a strong signal of problems with how a product is used, designed or made, and they cannot be ignored. One well-investigated complaint can prompt corrective action, while trends across many complaints can drive changes to a product, its labeling, packaging or distribution.
This session helps QA, QC, compliance, regulatory, engineering, operations, sales, customer service staff, managers and consultants decide whether a complaint is valid, find the root cause and prevent repeats.
- How and why CAPA is tied to product complaint investigations
- Tools currently used to conduct investigations
- How far and how deep to take an investigation
- Current FDA hot buttons and trends
- Benchmarks and best practices for investigations
- Becoming a good investigator and the focus on closed-loop investigations
- Why risk-based approaches are vital to decision-making
- Strengthening your product complaint management system through investigations
- Explain how CAPA links to product complaint investigations
- Choose suitable tools for complaint investigations
- Decide how far and how deep an investigation needs to go
- Recognize current FDA hot buttons and trends
- Apply risk-based approaches to complaint decisions
- Run closed-loop investigations using benchmarks and best practices
- Strengthen your complaint management system
- All levels of Management for all departments and those who desire a better understanding
- QA/QC/Compliance/Regulatory Affairs
- Marketing & Sales & Customer Service
- Engineering/Technical Services
- Consultants
- Operations and Manufacturing
Speaker Profile
David R. Dills
David Dills is currently a Global Regulatory Affairs Consultant after departing his last company earlier this year in 2024 and a full-service CRO as Director of Regulatory Services. He is a seasoned Global Regulatory Affairs, Regulatory Strategist, and Compliance professional with demonstrated capabilities and a track record with more than 35 years of accrued experience in the functional areas of Regulatory Affairs, Regulatory Intelligence, Regulatory Compliance, Global Regulatory PM/PD, and QA/QAE for US and international developers/manufacturers/sponsors for early-stage, mid- and large-size enterprises for pharma, biologics, combination, and medical device products from investigational to marketing approval. He has worked for CROs, …
Upcoming Webinars
Medical Device Cybersecurity Following FDA’s 2026 Premarket…
Managing Toxic Employees: Strategies For Leaders To Effecti…
California Meal and Rest Breaks: What You Don't Know Can Co…
Human Error Reduction Techniques for Floor Supervisors
Unlock Employee Loyalty: Stay Interviews Will Keep Them Eng…
Performance of Root Cause Analysis, CAPA, and Effectiveness…
Your AI Advantage: How HR Professionals Can Use Claude to S…
The Anti-Kickback Statute: Enforcement and Recent Updates
Empowering Conflict Resolution: Letting Go to Gain Control
Wage & Hour Laws: Ensuring Compliance with the Fair Labor S…
Using Copilot to Format Legal Documents in Microsoft Word
Dealing With Difficult People: At Work & In Life
Using Stay Interviews To Improve Employee Retention & Engag…
AI in Word - Smarter Writing and Document Creation with Cha…
FDA Current Trends in Compliance and Enforcement for FDA-Re…
Zero Acceptance Sampling to Reduce Inspection Costs
Why EBITDA Doesn't Spell Cash Flow and What Does?
Mastering Tough Conversations: Turn Conflict into Clarity, …
Enhancing Pivot Tables with Images: Visualize Your Data Lik…
Discover how Emotional Intelligence turns AI from a technic…
Understanding Financial Statements for Non-Financial Profes…
SOPs - How to Write Them to Satisfy those Inspectors
Managing Projects When AI Joins the Team: Human Judgment, A…